Tsuruha Holdings Inc. (TYO: 3391)
Japan
· Delayed Price · Currency is JPY
8,881.00
+94.00 (1.07%)
Jan 20, 2025, 3:30 PM JST
Tsuruha Holdings Revenue
Tsuruha Holdings had revenue of 273.41B JPY in the quarter ending August 15, 2024, with 5.23% growth. This brings the company's revenue in the last twelve months to 1.04T, up 5.50% year-over-year. In the fiscal year ending May 15, 2024, Tsuruha Holdings had annual revenue of 1.03T with 5.92% growth.
Revenue (ttm)
1,041.04B
Revenue Growth
+5.50%
P/S Ratio
0.41
Revenue / Employee
89.59M
Employees
11,620
Market Cap
432.22B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
May 15, 2024 | 1,027.46B | 57.38B | 5.92% |
May 15, 2023 | 970.08B | 54.38B | 5.94% |
May 15, 2022 | 915.70B | -3.60B | -0.39% |
May 15, 2021 | 919.30B | 78.27B | 9.31% |
May 15, 2020 | 841.04B | 58.59B | 7.49% |
May 15, 2019 | Pro | Pro | Pro |
May 15, 2018 | Pro | Pro | Pro |
May 15, 2017 | Pro | Pro | Pro |
May 15, 2016 | Pro | Pro | Pro |
May 15, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,142.35B |
Daiichi Sankyo Company | 1,758.07B |
HOYA Corporation | 812.74B |
Takeda Pharmaceutical Company | 4,546.08B |
Otsuka Holdings | 2,269.56B |
Terumo | 986.67B |
Astellas Pharma | 1,772.16B |
Olympus | 973.60B |